Premium
Orthobiologics for the Hip Region: A Narrative Review
Author(s) -
McInnis Kelly C.,
Chen Eric T.,
Finnoff Jonathan T.,
Roh Eugene Y.,
Borg Stein Joanne
Publication year - 2020
Publication title -
pmandr
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.617
H-Index - 66
eISSN - 1934-1563
pISSN - 1934-1482
DOI - 10.1002/pmrj.12327
Subject(s) - medicine , tendinopathy , narrative review , platelet rich plasma , hamstring , mesenchymal stem cell , osteoarthritis , physical therapy , surgery , intensive care medicine , tendon , pathology , alternative medicine , platelet
Management of hip region disorders is challenging. Orthobiologic treatments including platelet rich plasma (PRP), mesenchymal stem cells, and amniotic injectables have gained popularity as promising treatments despite a lack of robust evidence for their effectiveness. We review rationale and current evidence for orthobiologics for three common hip region conditions: hip osteoarthritis, gluteal tendinopathy, and proximal hamstring tendinopathy. Overall, the current state of evidence is extremely limited for orthobiologic treatments and is predominantly relevant to PRP injections. There is currently a lack of data to support the use of mesenchymal stem cells or amniotic injectables in these conditions of the hip.